GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint

GE HealthCare (Nasdaq: GEHC) today announced the launch of enhanced Venue ultrasound systems and a new solution setting the pace of point-of-care ultrasound (POCUS): Venue Sprint. The Venue Sprint is a new ultrasound device designed for maximum portability that combines the powerful, familiar Venue software and AI-enabled tools, uncompromised image quality, and wireless probe capability with Vscan Air handheld ultrasound systems. Other Venue family ultrasound systems will also now offer wireless probe connectivity, supplementary advanced clinical tools and the latest ViewPoint™ 6 updates for increased efficiency and optimized workflow.

POCUS continues to grow as a valuable tool for clinicians due to its portability and ability to provide detailed images that can offer real-time information and insights at the point of care. The use of POCUS is linked to accelerated diagnoses and treatment decisions, improved patient outcomes, increased treatment accuracy and lower healthcare costs.1 It represents a promising solution that can play a key role in reducing health inequities and expanding access across different care areas and various settings.1

“The Venue Sprint—and new enhancements to the Venue family—are designed to empower clinicians to deliver care wherever it is needed with the simplicity, flexibility and support they require to make confident clinical decisions,” said Karley Yoder, General Manager, Point of Care Ultrasound and Chief Digital Officer, Ultrasound at GE HealthCare. “We are excited to expand and enhance our point of care portfolio with unique solutions that build on our strengths in digital and handheld ultrasound to help clinicians navigate the evolving healthcare landscape.”

Venue Sprint is a portable system in a tablet form with wireless Vscan Air dual-probes enabling clinicians to provide care across a wide range of environments, including critical care, emergency medicine, medical transport, and more. This new ultrasound system brings excellent image quality and a common platform with other Venue systems to simplify the learning process and ensure a consistent experience. Venue Sprint includes AI-enabled resources and documentation tools designed to simplify manual processes and drive consistency - tools that can be found across the full Venue family.

Other Venue family ultrasound systems will also gain optional integration of wireless Vscan Air dual-probes, and all Venue family ultrasound systems have access to , which provides turn-by-turn, on-screen guidance to help capture diagnostic-quality cardiac ultrasound images. In addition, Venue ultrasound systems feature optional clinical tools to assist users of varying experience levels to conduct patient exams, including:

  • Bladder Volume Tool – Features reference images as guidance and supports clinicians in calculation of the bladder volume to make the process simple and fast.
  • Auto Volume Flow – Auto measurement tool calculating arterial flow volume in real-time.
  • Venue Coach MSK – Documentation tool that provides reference images and anatomy markups, and video tutorials to help users acquire the scans they need.
  • ViewPoint 6 ultrasound reporting software will now expand to Venue Sprint, bringing features like Direct Send that enables a silent workflow for clinicians to review, update and finalize on-board reports for added efficiency.
  • The latest release of ViewPoint 6 adds features and functionality to align with American College of Emergency Physicians (ACEP) guidelines, expand into new regions, and improve customer workflow with the ability to configure worksheet templates.

“Venue Sprint brings exceptional value to the emergency department, maintaining the proven quality of other Venue ultrasound systems while improving the user experience with wireless transducers,” said Andrés Carlos von Wernitz Teleki, MD, emergency medicine physician, Hospital Universitario de La Princesa, Madrid, Spain. “This versatile ultrasound system can be used for high-quality assessments in critical, time-sensitive scenarios where quick access to information is decisive for patient outcomes.”

GE HealthCare will showcase the robust Venue family ultrasound systems at the ACEP Scientific Assembly taking place on September 29 - October 2, 2024 in Las Vegas. The Venue family, including the Venue Sprint, are available in the U.S. and will launch in key countries around the globe this year. Caption Guidance on the Venue family is currently only available in the U.S.

For more information on Venue Sprint, visit: . To learn more about the latest Venue family solutions, visit: .

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on , , , , and for the latest news, or visit our website for more information.

1 Fraleigh, C. D. M., & Duff, E. (2022). Point-of-care ultrasound: An emerging clinical tool to enhance physical assessment. The Nurse practitioner, 47(8), 14–20.

EN
19/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare Technologies Inc.: Building a solid stand-alone track re...

Our credit view of this issuer reflects its strong base of stable, recurring revenues from services and consumables, offset by its competitive market environment.

 PRESS RELEASE

GE HealthCare reports third quarter 2024 financial results

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2024. GE HealthCare President and CEO Peter Arduini said, “In the third quarter, we reported sales and orders growth of 1% globally. Both sales and orders grew in the mid-single digits excluding China, with particular strength in the U.S. across all segments. Pharmaceutical Diagnostics also delivered solid performance, driven by healthy procedure volumes. Ongoing lean initiatives across the organization are delivering better value to patients and customers and hav...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of GE HealthCare Technologies Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 23 October 2024 in which we reassessed the appropriateness of the ratings i...

 PRESS RELEASE

GE HealthCare announces CareIntellect for Oncology, harnessing AI to g...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems into a single view, using generative AI to summarize clinical notes and reports. The application also surfaces relevant data allowing care teams to quickly understand disease progression and flag potential deviations from the treatment plan to help the clinician determine potential next steps and inform proactive interventions. The application, which is planned to be available to customers in U.S. ...

 PRESS RELEASE

GE HealthCare Announces AI Innovation Lab Showcasing Five New Research...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company. These projects are one part of GE HealthCare’s broader AI and digital strategy, which is focused on integrating AI into medical devices, building AI applications that enhance decision-making across the care journey and disease states, and using AI to support better outcomes and operational efficiencies system-wide. The company’s investment in cloud technology underpins this strategy, providing the computing power ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch